These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21689940)

  • 1. Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2 receptor antagonists.
    Roberts K; Ursini A; Barnaby R; Cassarà PG; Corsi M; Curotto G; Donati D; Feriani A; Finizia G; Marchioro C; Niccolai D; Oliosi B; Polinelli S; Ratti E; Reggiani A; Tedesco G; Tranquillini ME; Trist DG; van Amsterdam FT
    Bioorg Med Chem; 2011 Jul; 19(14):4257-73. PubMed ID: 21689940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Garsky VM; Gilbert KF; Leighton JL; Carson KL; Mellin EC
    J Med Chem; 1993 Dec; 36(26):4276-92. PubMed ID: 8277510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
    Ursini A; Capelli AM; Carr RA; Cassarà P; Corsi M; Curcuruto O; Curotto G; Dal Cin M; Davalli S; Donati D; Feriani A; Finch H; Finizia G; Gaviraghi G; Marien M; Pentassuglia G; Polinelli S; Ratti E; Reggiani AM; Tarzia G; Tedesco G; Tranquillini ME; Trist DG; Van Amsterdam FT
    J Med Chem; 2000 Oct; 43(20):3596-613. PubMed ID: 11020274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
    Micale N; Colleoni S; Postorino G; Pellicanò A; Zappalà M; Lazzaro J; Diana V; Cagnotto A; Mennini T; Grasso S
    Bioorg Med Chem; 2008 Mar; 16(5):2200-11. PubMed ID: 18083036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-ones and their evaluation as cholecystokinin-ligands.
    Offel M; Lattmann P; Singh H; Billington DC; Bunprakob Y; Sattayasai J; Lattmann E
    Arch Pharm (Weinheim); 2006 Apr; 339(4):163-73. PubMed ID: 16572480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists.
    Lattmann E; Billington DC; Poyner DR; Howitt SB; Offel M
    Drug Des Discov; 2001; 17(3):219-30. PubMed ID: 11469752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas.
    Castro JL; Ball RG; Broughton HB; Russell MG; Rathbone D; Watt AP; Baker R; Chapman KL; Fletcher AE; Patel S; Smith AJ; Marshall GR; Ryecroft W; Matassa VG
    J Med Chem; 1996 Feb; 39(4):842-9. PubMed ID: 8632408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability.
    Morton MF; Barrett TD; Freedman J; Li L; Rizzolio MC; Prendergast CE; Wu X; Moreno V; Pyati J; Figueroa K; Cagnon L; Lagaud G; Ver Donck L; Ghoos E; Allison B; Rabinowitz MH; Shankley NP
    J Pharmacol Exp Ther; 2011 Jul; 338(1):328-36. PubMed ID: 21493750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
    Fornai M; Colucci R; Antonioli L; Baschiera F; Ghisu N; Tuccori M; Gori G; Blandizzi C; Del Tacca M
    Eur J Pharmacol; 2007 Feb; 557(2-3):212-20. PubMed ID: 17208221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate.
    Henderson EA; Alber DG; Baxter RC; Bithell SK; Budworth J; Carter MC; Chubb A; Cockerill GS; Dowdell VC; Fraser IJ; Harris RA; Keegan SJ; Kelsey RD; Lumley JA; Stables JN; Weerasekera N; Wilson LJ; Powell KL
    J Med Chem; 2007 Apr; 50(7):1685-92. PubMed ID: 17341059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, chiral resolution, and enantiopharmacology of a potent 2,3-benzodiazepine derivative as noncompetitive AMPA receptor antagonist.
    Zappalà M; Postorino G; Micale N; Caccamese S; Parrinello N; Grazioso G; Roda G; Menniti FS; De Sarro G; Grasso S
    J Med Chem; 2006 Jan; 49(2):575-81. PubMed ID: 16420043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.
    Allison BD; Phuong VK; McAtee LC; Rosen M; Morton M; Prendergast C; Barrett T; Lagaud G; Freedman J; Li L; Wu X; Venkatesan H; Pippel M; Woods C; Rizzolio MC; Hack M; Hoey K; Deng X; King C; Shankley NP; Rabinowitz MH
    J Med Chem; 2006 Oct; 49(21):6371-90. PubMed ID: 17034143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors.
    McDonald IM; Austin C; Buck IM; Dunstone DJ; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Pether MJ; Spencer J; Wright PT; Adatia T; Bashall A
    J Med Chem; 2006 Apr; 49(7):2253-61. PubMed ID: 16570921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
    Henke BR; Aquino CJ; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; Hirst GC; James MK; Johnson MF; Queen KL; Sherrill RG; Sugg EE; Suh EM; Szewczyk JW; Unwalla RJ; Yingling J; Willson TM
    J Med Chem; 1997 Aug; 40(17):2706-25. PubMed ID: 9276016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
    Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
    J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template.
    Spencer J; Gaffen J; Griffin E; Harper EA; Linney ID; McDonald IM; Roberts SP; Shaxted ME; Adatia T; Bashall A
    Bioorg Med Chem; 2008 Mar; 16(6):2974-83. PubMed ID: 18289857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
    J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1).
    Lattmann E; Billington DC; Poyner DR; Arayarat P; Howitt SB; Lawrence S; Offel M
    Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.
    McDonald IM; Black JW; Buck IM; Dunstone DJ; Griffin EP; Harper EA; Hull RA; Kalindjian SB; Lilley EJ; Linney ID; Pether MJ; Roberts SP; Shaxted ME; Spencer J; Steel KI; Sykes DA; Walker MK; Watt GF; Wright L; Wright PT; Xun W
    J Med Chem; 2007 Jun; 50(13):3101-12. PubMed ID: 17536796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.